ABSTRACT
Purpose
This study aimed to examine the impact of CA on DN and elucidate its underlying molecular mechanisms of inflammation.
Methods
We fed C57BL/6 mice injected with streptozotocin to induce diabetes. In addition, we stimulated NRK-52E cells with 20 mmol/L d-glucose to mimic the diabetic condition.
Results
Our findings demonstrated that CA effectively reduced blood glucose levels, and improved DN in mice models. Additionally, CA reduced kidney injury and inflammation in both mice models and in vitro models. CA decreased high glucose-induced ferroptosis of NRK-52E cells by inducing GSH/GPX4 axis. Conversely, the ferroptosis activator or the PI3K inhibitor reversed positive effects of CA on DN in both mice and in vitro models. CA suppressed PAQR3 expression in DN models to promote PI3K/AKT activity. The PAQR3 activator reduced the positive effects of CA on DN in vitro models. Moreover, CA directly targeted the PAQR3 protein to enhance the ubiquitination of the PAQR3 protein.
Conclusion
Overall, our study has uncovered that CA promotes the ubiquitination of PAQR3, leading to the attenuation of ferroptosis in DN. This effect is achieved through the activation of the PI3K/AKT signaling pathways by disrupting the interaction between PAQR3 and the P110α pathway. These findings highlight the potential of CA as a viable therapeutic option for the prevention of DN and other forms of diabetes.
Graphical abstract
Acknowledgments
This work was supported by National Natural Science Foundation of China (811731333); Key Natural Science Projects of the Department of Education of Anhui province (2022AH051239, 2023AH051767); Talent Introduction Program of Yijishan Hospital of Wannan Medical College (YR202005); Science and Technology Innovation Team of Yijishan Hospital of Wannan Medical College (YPF2019016, YR20230105), and Key projects of Wannan Medical (WK2021ZF11, KY23740650). Thanks to the central laboratory for its support to this research.
Disclosure statement
We wish to confirm that there are no known conflicts of interest associated with this publication and there has been no significant financial support for this work that could have influenced its outcome.
Authors’ contribution
Zhichen Pu and Yong Liu conceived the study, designed the study and prepared the manuscript. Yong Liu and Jiajun Zhou conducted the experiments and data analysis, involved in preparation of the figures and manuscript. All data were generated in-house, and no paper mill was used. All authors agree to be accountable for all aspects of work ensuring integrity and accuracy.
Abbreviations
DN | = | Diabetic nephropathy |
CA | = | Cichoric acid |
P AQR3 | = | Progestin and adipo Q acceptor 3, |
GPX4 | = | glutathione peroxidase 4 |
PI3K | = | Phosphatidylinositol-4,5-bisphosphate 3-kinase |
Akt | = | protein kinase B |
Nrf2 | = | Nuclear factor E2-related factor 2 |
HFD | = | high-fat diet |
STZ | = | streptozotocin |
Qpcr | = | Quantitative polymerase chain reaction |
CCK8 | = | Cell counting kit‑8 |
MST | = | Microscale thermophoresis |
TSA | = | Thermal shift assay |
CETSA | = | cellular thermal shift assay |
co-IP | = | co-immunoprecipitation |